Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC

Name: Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC
License: Public Domain

The First Affiliated Hospital with Nanjing Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non-small-cell-lung-cancer

non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174860
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.